Chou Judy

Insider Reports History

Location
C/O Akero Therapeutics, Inc., 601 Gateway Blvd, Suite 350, South San Francisco, CA
Signature
/s/ Jonathan Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chou Judy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akero Therapeutics, Inc. Director Common Stock 9.4K $422K $44.92 Jun 3, 2025 Direct
Akero Therapeutics, Inc. Director Stock Option (Right to Buy) 26K Jun 8, 2024 Direct

Insider Reports Filed by Chou Judy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKRO Akero Therapeutics, Inc. Jun 3, 2025 1 $0 4 Jun 5, 2025 Director
AKRO Akero Therapeutics, Inc. Jun 8, 2024 1 $0 4 Jun 11, 2024 Director
AKRO Akero Therapeutics, Inc. Jun 23, 2023 1 $0 4 Jun 27, 2023 Director
AKRO Akero Therapeutics, Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
AKRO Akero Therapeutics, Inc. Jul 12, 2021 1 $0 4 Jul 14, 2021 Director
AKRO Akero Therapeutics, Inc. Jul 12, 2021 0 $0 3 Jul 14, 2021 Director